These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

961 related items for PubMed ID: 16202788

  • 1. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ, Hoffman G, Laessig RH, Kopish GJ, Litsheim TJ, Farrell PM.
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB, Comeau AM.
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [Abstract] [Full Text] [Related]

  • 4. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM, Koscik RE.
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [Abstract] [Full Text] [Related]

  • 5. Sweat testing infants detected by cystic fibrosis newborn screening.
    Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP.
    J Pediatr; 2005 Sep; 147(3 Suppl):S69-72. PubMed ID: 16202787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB.
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C, Seia M, Bassotti A, Ambrosioni A, Giunta A, Padoan R.
    J Med Screen; 2002 Jun; 9(2):60-3. PubMed ID: 12133923
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Neonatal screening for cystic fibrosis].
    Tellería Orriols JJ, Alonso Ramos MJ, Garrote Adrados JA, Fernández Carvajal I, Blanco Quirós A.
    An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL, Desai H, Platt M, Dixon M.
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [Abstract] [Full Text] [Related]

  • 14. Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.
    Massie J, Curnow L, Tzanakos N, Francis I, Robertson CF.
    Arch Dis Child; 2006 Mar; 91(3):222-5. PubMed ID: 16243854
    [Abstract] [Full Text] [Related]

  • 15. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A, Koscik RL, Farrell PM, Rock MJ.
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [Abstract] [Full Text] [Related]

  • 16. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
    Keiles S, Koepke R, Parad R, Kharrazi M, California Cystic Fibrosis Newborn Screening Consortium.
    J Cyst Fibros; 2012 May; 11(3):257-60. PubMed ID: 22209734
    [Abstract] [Full Text] [Related]

  • 17. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
    Sontag MK, Wright D, Beebe J, Accurso FJ, Sagel SD.
    J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
    [Abstract] [Full Text] [Related]

  • 18. Screening for cystic fibrosis in dried blood spots of newborns.
    Audrézet MP, Costes B, Ghanem N, Fanen P, Verlingue C, Morin JF, Mercier B, Goossens M, Férec C.
    Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
    [Abstract] [Full Text] [Related]

  • 19. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
    Sommerburg O, Lindner M, Muckenthaler M, Kohlmueller D, Leible S, Feneberg R, Kulozik AE, Mall MA, Hoffmann GF.
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
    [Abstract] [Full Text] [Related]

  • 20. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing.
    Farrell PM, Aronson RA, Hoffman G, Laessig RH.
    Wis Med J; 1994 Aug; 93(8):415-21. PubMed ID: 7975706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.